SCHEMBL9019742

SCHEMBL9019742

CC(=O)Nc1nc(N)c2c(ncn2COC(COC(C)C)COC(C)C)n1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.33
PDE3A Q14432 1/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
NFKB1 P19838 1/20 0.32
BLM P54132 1/20 0.32
VCP P55072 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
TKT P29401 1/20 0.31
BCHE P06276 1/20 0.31
CYP1A2 P05177 1/20 0.31
PRKD3 O94806 1/20 0.31
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9021299 0.88 ACHE (0.42) ACHEBCHECYP1A2
SCHEMBL9019784 0.88 ALDH1A1 (0.36) ACHEALDH1A1BCHECYP1A2
SCHEMBL9019743 0.88 ACHE (0.33) ACHEBCHE
SCHEMBL9019807 0.84 PDE3A (0.32) PDE3ALMNAMEN1ALDH1A1CYP3A4
SCHEMBL9019783 0.81 ADORA2A (0.35) PDE3ALMNAMEN1ALDH1A1CYP3A4
SCHEMBL9019764 0.79 PDE3A (0.38) PDE3ALMNAMEN1ALDH1A1CYP3A4
SCHEMBL9019840 0.79 HPGD (0.46) PDE3AMEN1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL9021161 0.79 BCHE (0.50) ACHELMNABCHE
SCHEMBL9021782 0.79 ACHE (0.43) ACHEBCHECYP1A2
SCHEMBL9575559 0.77 ALDH1A1 (0.41) PDE3ALMNAMEN1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed